Hyoscine Butylbromide, a compound with the chemical formula C21H30BrNO4 and CAS number 149-64-4, is a testament to the intricate science of pharmaceutical manufacturing. NINGBO INNO PHARMCHEM CO.,LTD. specializes in producing this vital medicine raw material in a pure powder form, essential for its role as an pharmaceutical intermediate antispasmodic.

The synthesis of Hyoscine Butylbromide typically involves the quaternization of hyoscine (scopolamine) with n-butyl bromide. This process yields a quaternary ammonium compound, which is crucial for its pharmacological action. The resulting white powder is characterized by high purity, often exceeding 99%, ensuring its suitability for pharmaceutical applications that demand precise dosing and therapeutic effectiveness. The ability to buy hyoscine butylbromide powder with such specifications is fundamental for drug developers.

At NINGBO INNO PHARMCHEM CO.,LTD., the manufacturing process is meticulously controlled to maintain the integrity and quality of the Hyoscine Butylbromide powder. From raw material sourcing to final product packaging, every step is designed to meet stringent industry standards. This dedication ensures that when you buy hyoscine butylbromide powder, you receive a product that consistently delivers the expected antispasmodic effects, vital for applications such as IBS pain relief medicine and general relief from abdominal cramps.

Understanding the chemical properties of Hyoscine Butylbromide powder also informs its various hyoscine butylbromide powder uses. Its structure contributes to its peripheral action, minimizing central nervous system effects, which is a significant advantage in its therapeutic applications. The availability of hyoscine butylbromide for sale from a reputable manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. guarantees that these critical chemical characteristics are preserved.

In essence, the production of high-grade Hyoscine Butylbromide powder is a cornerstone of NINGBO INNO PHARMCHEM CO.,LTD.'s offerings. Our commitment to quality manufacturing ensures that pharmaceutical partners have access to a reliable and pure antispasmodic intermediate, supporting the creation of essential medicines.